Andere Sprachen Evofem Biosciences, Inc.

Aktien

A3D9Z3

US30048L3024

EVFM

Markt geschlossen - OTC Markets Andere Börsenplätze 21:54:47 17.04.2024			% 5 Tage	% 1. Jan.
0.0136 ^USD	-11.11%		-24.02%	-78.75%

27.03.	Evofem Biosciences, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
27.03.	Evofem Biosciences, Inc. meldet Ergebnis für das vierte Quartal zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023	27.03.
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27.03.
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal	20.03.
Evofem Biosciences - For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy	08.03.
Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game	08.01.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI	19.12.
EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM	18.12.
North American Morning Briefing : Dow Set For New -2-	14.12.
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi, the First and Only FDA-Approved Hormone-Free Contraceptive Gel	13.12.
Shareholder Alert: Ademi LLP investigates whether Evofem Biosciences, Inc. has obtained a Fair Price in its transaction with Aditxt	12.12.
EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders	12.12.
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023	14.11.
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Evofem Biosciences : Presentation	01.11.
OTC Stocks News-Based Catalyst Watchlist (IMRFF, BLFR, NILIF, EVFM)	25.10.23
Evofem Biosciences : EVFM at a Glance	24.10.23
Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023	24.10.23
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023	24.10.23
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi until Evofem's Phexxi Patents Expire	28.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evofem Biosciences, Inc.

Aktien

A3D9Z3

US30048L3024

EVFM

Andere Sprachen

Filter